The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
Abstract
CONTEXT: No pharmacological therapeutic protocol has been found effective in modifying the clinical course of acute respiratory distress syndrome (ARDS) and mortality remains greater than 50%. OBJECTIVE: To determine the effects of prolonged methylprednisolone therapy on lung function and mortality in patients with unresolving ARDS. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: Medical intensive care units of 4 medical centers. PARTICIPANTS: Twenty-four patients with severe ARDS who had failed to improve lung injury score (LIS) by the seventh day of respiratory failure. INTERVENTIONS: Sixteen patients received methylprednisolone and 8 received placebo. Methylprednisolone dose was initially 2 mg/kg per day and the duration of treatment was 32 days. Four patients whose LIS failed to improve by at least 1 point after 10 days of treatment were blindly crossed over to the alternative treatment. MAIN OUTCOME MEASURES: Primary outcome measures were improvement in lung function and mortality. Secondary outcome measures were improvement in multiple organ dysfunction syndrome (MODS) and development of nosocomial infections. RESULTS: Physiological characteristics at the onset of ARDS were similar in both groups. At study entry (day 9 [SD, 3] of ARDS), the 2 groups had similar LIS, ratios of PaO2 to fraction of inspired oxygen (FIO2), and MODS scores. Changes observed by study day 10 for methylprednisolone vs placebo were as follows: reduced LIS (mean [SEM], 1.7 [0.1] vs 3.0 [0.2]; P<.001); improved ratio of PaO2 to FIO2 (mean [SEM], 262 [19] vs 148 [35]; P<.001); decreased MODS score (mean [SEM], 0.7 [0.2] vs 1.8 [0.3]; P<.001); and successful extubation (7 vs 0; P=.05). For the treatment group vs the placebo group, mortality associated with the intensive care unit was 0 (0%) of 16 vs 5 (62%) of 8 (P=.002) and hospital-associated mortality was 2 (12%) of 16 vs 5 (62%) of 8 (P=.03). The rate of infections per day of treatment was similar in both groups, and pneumonia was frequently detected in the absence of fever. CONCLUSIONS: In this study, prolonged administration of methylprednisolone in patients with unresolving ARDS was associated with improvement in lung injury and MODS scores and reduced mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,646
High-Dose Corticosteroids in Patients with the Adult Respiratory Distress Syndrome
Bernard, G. R., Luce, J. M., Sprung, C. L., Rinaldo, J. E., Tate, R. M., Sibbald, W. J., Kariman, K., Higgins, S., Bradley, R., Metz, C. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172504 · Cited by 935
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., & Leeper, K. (1995) · Chest · doi:10.1378/chest.107.4.1062 · Cited by 789
Self-citationInflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Self-citationThe Design and Analysis of Sequential Clinical Trials.
Harrington, D., & Whitehead, J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288093 · Cited by 634
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622
The Acute Respiratory Distress Syndrome
Kollef, M. H., & Schuster, D. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320106 · Cited by 550
Steroid controversy in sepsis and septic shock: A meta-analysis
Lefering, R., & Neugebauer, E. A. M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199507000-00021 · Cited by 485
Early Methylprednisolone Treatment for Septic Syndrome and the Adult Respiratory Distress Syndrome
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., & Metz, C. A. (1987) · Chest · doi:10.1378/chest.92.6.1032 · Cited by 367
Meduri, G. U., Mauldin, G. L., Wunderink, R. G., Leeper, K. V., Jones, C. B., Tolley, E., & Mayhall, G. (1994) · Chest · doi:10.1378/chest.106.1.221 · Cited by 339
Self-citationFibroproliferative Phase of ARDS
Meduri, G. U., Belenchia, J. M., Estes, R. J., Wunderink, R. G., Torky, M. E., & Leeper, K. V. (1991) · Chest · doi:10.1378/chest.100.4.943 · Cited by 306
Self-citationThe Standardization of Bronchoscopic Techniques for Ventilator-Associated Pneumonia
Meduri, G. U., & Chastre, J. (1992) · Chest · doi:10.1378/chest.102.5_supplement_1.557s · Cited by 293
Self-citationGlucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man
Barber, A. E., Coyle, S. M., Marano, M. A., Fischer, E., Calvano, S. E., Fong, Y., Moldawer, L. L., & Lowry, S. F. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1999 · Cited by 285
Corticosteroid Rescue Treatment of Progressive Fibroproliferation in Late ARDS
Umberto Meduri, G., Chinn, A. J., Leeper, K. V., Wunderink, R. G., Tolley, E., Winer-Muram, H. T., Khare, V., & Eltorky, M. (1994) · Chest · doi:10.1378/chest.105.5.1516 · Cited by 277
Self-citationInfections and the Inflammatory Response in Acute Respiratory Distress Syndrome
Headley, A. S., Meduri, G. U., & Tolley, E. (1997) · Chest · doi:10.1378/chest.111.5.1306 · Cited by 259
Self-citationKrafft, P., Fridrich, P., Pernerstorfer, T., Fitzgerald, R. D., Koc, D., Schneider, B., Hammerle, A. F., & Steltzer, H. (1996) · Intensive Care Medicine · doi:10.1007/bf01708091 · Cited by 244
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
Lew, K. H., Ludwig, E. A., Milad, M. A., Donovan, K., Jr., E. M., Ferry, J. J., & Jusko, W. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.167 · Cited by 169
Idiopathic Pulmonary Fibrosis in Adult Respiratory Distress Syndrome: Diagnosis and Treatment
Ashbaugh, D. G. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390290012002 · Cited by 163
An Early Test of Survival in Patients with the Adult Respiratory Distress Syndrome
Bone, R. C., Maunder, R., Slotman, G., Silverman, H., Hyers, T. M., Kerstein, M. D., & Ursprung, J. J. (1989) · Chest · doi:10.1378/chest.96.4.849 · Cited by 160
Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome
Briegel, J., Kellermann, W., Forst, H., Haller, M., Bittl, M., Hoffmann, G. E., B�chler, M. W., Uhl, W. H., Peter, K., & Phospholipase A2 Study Group (1994) · Journal of Molecular Medicine · doi:10.1007/bf00180547 · Cited by 151
Plasma and BAL Cytokine Response to Corticosteroid Rescue Treatment in Late ARDS
Meduri, G. U., Headley, S., Tolley, E. A., Shelby, M., Stentz, F. B., & Postlethwaite, A. E. (1995) · CHEST Journal · doi:10.1378/chest.108.5.1315 · Cited by 140
Self-citationMeduri, G. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122650 · Cited by 131
Self-citationShen, A. S., Haslett, C., Feldsien, D. C., Henson, P. M., & Cherniack, R. M. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.3.564 · Cited by 77
The fibroproliferative phase of late adult respiratory distress syndrome.
Meduri, G. U., Eltorky, M., & WINER-MURAM, H. T. (1995) · PubMed · Cited by 51
Self-citationPharmacokinetics of methylprednisolone in elderly and young healthy males
Tornatore, K. M., Logue, G., Venuto, R. C., & Davis, P. J. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06219.x · Cited by 38
Cited by
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Ranieri, V. M., Suter, P. M., Tortorella, C., De Tullio, R., Dayer, J. M., Brienza, A., Bruno, F., & Slutsky, A. S. (1999) · JAMA · doi:10.1001/jama.282.1.54 · Cited by 1,908
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
De Jonghe, B. (2002) · JAMA · doi:10.1001/jama.288.22.2859 · Cited by 1,516
Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa051693 · Cited by 1,498
Metadata
- Authors
- Meduri, G. U., Headley, A. S., Golden, E., Carson, S. J., Umberger, R. A., Kelso, T., & Tolley, E. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-07-08
- Volume
- 280
- Issue
- 2
- Pages
- 159
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1999319544
- Cited by
- 1,008
- References
- 31
- FWCI
- 41.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.